1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Cancer-associated Cachexia: new trials by email Literature Review of Cancer-associated Cachexia trials Research Report on Cancer-associated Cachexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Visugromab in Cachexia International Trial Visugromab (CTL-002), Placebo - Cancer-associated Cachexia | Phase 2 / Phase 3 | Recruiting | CatalYm GmbH | 518 | 2026-04-16 | 2026-11-02 |
Anorexia (1) · Cachexia (1) · Neoplasms (1) · Weight Loss (1)
Body Weight (1) · Body Weight Changes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Thinness (1)
CatalYm GmbH (1)
Bulgaria (1) · Czechia (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Romania (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)